Intravitreal Bevacizumab Stabilizes Subfoveal CNV Secondary To AMD At 2 Years

Ocular surgery News

Intravitreal bevacizumab improved visual acuity and macular thickness in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration, a study found.
  • <<
  • >>

Comments